On November 17, 2026, FINRA announced that Spartan Capital Securities, LLC will pay $2,176,398.20 in restitution to customers and a $1 million fine, and will be censured, to resolve a pending disciplinary complaint over its sale of pre-IPO private placements. The firm’s former CEO, John Lowry, received a two-year suspension in all capacities and a $25,000 fine. Kim Monchik, the firm’s former chief administrative officer and acting chief compliance officer, was barred from associating with any FINRA member firm.
This was not an AWC. It is an Order Accepting Offer of Settlement, dated October 22, 2026, in Disciplinary Proceeding No. 2021069218305, which FINRA’s Department of Enforcement filed as a complaint on November 24, 2025. The respondents consented to the findings and sanctions without admitting or denying the allegations of the complaint, as amended by the offer.
The Atlas Funds Structure
According to the order, Lowry created three private funds, Atlas Fund III, LLC, Atlas Fund IV, LLC and Atlas Fund V, LLC, to give Spartan customers a way into pre-IPO companies. He owned and controlled the funds’ manager, Atlas Fund Management LLC, and he decided that Spartan would be the sole placement agent and keep a 10 percent placement fee.
The structure had several layers. Investors bought membership interests in a series of an Atlas Fund. The Atlas Fund then bought interests in SP Venture Fund 8, LLC, a fund managed by StraightPath Venture Partners, LLC, which purported to hold shares of a specific pre-IPO company. On top of the placement fee, investors paid a 2 percent management fee and a 20 percent carried interest.
Between March and October 2021, Spartan made 344 recommendations in 16 offerings, totaling approximately $24 million, to 186 customers. Of those, 332 were to retail customers.
The Markups
The heart of the fraud finding is the markups. According to the order, the private placement memoranda told investors that the Atlas Funds would not share in any profit on markups a third-party affiliate might charge. The offering supplements said the Atlas Funds would buy the pre-IPO interests from an affiliate, Iapetus, LLC, at a markup over what Iapetus paid.
FINRA found that none of that happened. Iapetus never bought anything. The Atlas Funds bought directly from the StraightPath fund and then applied the markup themselves before selling to customers. The order gives an example. In the “Company One” offering, the Atlas Funds paid a per-share equivalent of $1,450, and investors were charged $1,635, a $185 (12.75 percent) markup.
Lowry caused markups on 15 of the 16 offerings. They ranged from 12.75 percent to 36.4 percent and totaled approximately $3.25 million, all of which benefited entities Lowry owned and controlled. FINRA found that the respondents acted recklessly or, at a minimum, negligently. That violated FINRA Rule 2010, both on its own and by acting in contravention of Sections 17(a)(2) and (3) of the Securities Act of 1933.
Markups in private placements are not illegal on their own. Sponsors and placement agents get paid, and investors generally understand that. The problem here, according to the order, is that the offering documents described one arrangement and the money moved another way. The documents said an affiliate would charge the markup and the funds would not share in it. Then the funds took the markup themselves, for the benefit of entities the CEO owned. When the disclosure and the reality don’t match, regulators will call it fraud, not a paperwork problem.
Due Diligence and Regulation Best Interest
The order describes Monchik as the person responsible for due diligence on both sides of the deal, first for the Atlas Funds and then for Spartan. She spent about 40 percent of her time on the Atlas entities while serving as Spartan’s interim CCO.
FINRA found that her diligence on StraightPath consisted largely of limited internet searches and background checks, including a Lexis search of an unrelated Georgia company with a similar name. She never confirmed that the StraightPath fund actually held the pre-IPO shares. When StraightPath produced documents for only some of the offerings, and none of them established possession of the shares, Spartan representatives kept selling, including eight new offerings. She did not document any analysis of pricing or markups.
StraightPath is now in a receivership arising from SEC litigation. According to the FINRA release, three former StraightPath principals were sentenced in May to eight to 11 years in federal prison in a separate criminal case unrelated to Spartan.
On these findings, Spartan willfully violated Regulation Best Interest’s Care Obligation under Exchange Act Rule 15l-1(a)(1), and also violated FINRA Rules 2111 and 2010. Spartan also willfully violated Reg BI’s Disclosure Obligation by failing to fully and fairly disclose Lowry’s ownership and economic stake and Monchik’s dual role.
I see this pattern often. The person who vets a deal for the issuer cannot also be the independent check for the broker-dealer selling it. Reg BI’s Care Obligation requires a reasonable basis for the recommendation, and in a pre-IPO fund deal the most basic question is whether the fund actually owns the shares it says it owns. If no one at the firm can answer that question with documents, the firm should not be selling the product.
Supervision and Written Procedures
The order also found that Spartan’s written supervisory procedures had no provisions to achieve compliance with Reg BI’s Care Obligation for private placements. They did not name a principal responsible for due diligence, list specific diligence steps, or require anyone to check whether an issuer actually had the shares it was selling. Spartan had no written policies at all on identifying, disclosing or mitigating conflicts of interest, including conflicts from selling offerings issued by its CEO’s own affiliates.
As a result, Spartan willfully violated Exchange Act Rule 15l-1(a)(1), and Spartan and Monchik violated FINRA Rules 3110(a) and (b) and 2010.
The Sanctions and the Background
Under the order:
- Spartan is censured, fined $1,000,000, and must pay restitution of $2,176,398.20 to the eligible customers listed in an attachment.
- Lowry is suspended from associating with any FINRA member firm in all capacities for two years and fined $25,000. The fine is due when he re-associates with a member firm or applies for relief from a statutory disqualification, whichever comes first.
- Monchik is barred from associating with any FINRA member firm in all capacities.
The order notes that the restitution does not preclude customers from pursuing their own actions for restitution or other remedies.
This is not the first proceeding involving these respondents. The order recites an October 2024 NAC decision, now on appeal to the SEC, involving Form U4 disclosure violations, and a March 2026 hearing panel decision, now on appeal to the NAC, involving FINRA Rule 8210. Spartan terminated both Lowry’s and Monchik’s registrations on May 29, 2026.
For firms that sell affiliated private placements, the lessons are practical. Keep due diligence away from the people who profit from the deal, document what you did, verify that the issuer holds what it is selling, and write supervisory procedures that specifically address private placements and conflicts of interest. For investors who bought these offerings, the order expressly says restitution does not stop you from pursuing your own remedies. FINRA arbitration may be available, and timing matters, so speak with counsel about your options.
If you are a broker-dealer, a registered representative or an investor with questions about private placement due diligence, Reg BI or a FINRA investigation, contact me.
This post is for general information only and is not legal advice.
Sources:
- FINRA News Release, “FINRA Orders Spartan Capital Securities to Pay $3.18 Million for Fraud and Private Placement Supervisory Failures” (Nov. 17, 2026)
- Order Accepting Offer of Settlement, Dep’t of Enforcement v. Spartan Capital Securities, LLC, John Lowry and Kim Monchik, Disciplinary Proceeding No. 2021069218305 (Oct. 22, 2026) (PDF)
Mark J. Astarita, Esq.
Sallah Astarita & Cox, LLC
11 Broadway, Suite 615, New York, NY 10004
(212) 509-6544 | Direct: (973) 559-5795
mja@sallahlaw.com
seclaw.com | securitieslawyer.us | sallahlaw.com
Mark Astarita is a nationally recognized securities attorney, who represents investors, financial professionals and firms in securities litigation, arbitration and regulatory matters, including SEC and FINRA investigations and enforcement proceedings.
He is a partner in the national securities law firm Sallah Astarita & Cox, LLC, and the founder of The Securities Law Home Page - SECLaw.com, which was one of the first legal topic sites on the Internet. It went online in 1995 and is updated daily with news, commentary and securities law related links.
Discover more from SECLaw
Subscribe to get the latest posts sent to your email.






